Vimarsana
Biggest News Aggregation in the World

Page 6 - Skye Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Skye Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Skye Bioscience Today - Breaking & Trending Today

CA District Court: Insurance Policy Covering Securities Claims May Extend to SOX Whistleblower Claims | Proskauer - Whistleblowing & Retaliation - Vimarsana News

CA District Court: Insurance Policy Covering Securities Claims May Extend to SOX Whistleblower Claims | Proskauer - Whistleblowing & Retaliation

A recent California district court addressed the question of whether, for insurance coverage purposes, a SOX whistleblower claim is a “securities claim,” and answered that question in...

Skye Bioscience, Inc. (OTCMKTS:SKYE) Short Interest Update - Vimarsana News

Skye Bioscience, Inc. (OTCMKTS:SKYE) Short Interest Update

Skye Bioscience, Inc. (OTCMKTS:SKYE – Get Free Report) saw a significant growth in short interest in the month of August. As of August 15th, there was short interest totalling 73,800 shares, a growth of 63.6% from the July 31st total of 45,100 shares. Based on an average daily trading volume, of 2,428,000 shares, the days-to-cover […]

Source: wkrb13.com
Skye Bioscience, Inc. (OTCMKTS:SKYE) Sees Large Increase in Short Interest - Vimarsana News

Skye Bioscience, Inc. (OTCMKTS:SKYE) Sees Large Increase in Short Interest

Skye Bioscience, Inc. (OTCMKTS:SKYE – Get Free Report) was the recipient of a large growth in short interest during the month of August. As of August 15th, there was short interest totalling 73,800 shares, a growth of 63.6% from the July 31st total of 45,100 shares. Based on an average daily volume of 2,428,000 shares, […]

CapitalGainsReport News Catalyst Watchlist (EPAZ, SKYE, NVOS, VEDU) - Vimarsana News

CapitalGainsReport News Catalyst Watchlist (EPAZ, SKYE, NVOS, VEDU)

Staying well-informed about a company's news releases and updates is paramount in the world of trading. These announcements often hold the key to understanding a company's performance, growth...

Skye Secures $17M And Acquires Novel Phase 2-Ready Cannabinoid 1 Receptor Inhibitor - Skye Bioscience (OTC:SKYE) - Vimarsana News

Skye Secures $17M And Acquires Novel Phase 2-Ready Cannabinoid 1 Receptor Inhibitor - Skye Bioscience (OTC:SKYE)

Skye Bioscience, Inc. (OTCQB: SKYE) has undertaken a strategic initiative that expands the company's resources and technologies focused on developing therapeutic products focused on the endocannabinoid system ("ECS").